最新的研究结果挑战了行为方法来管理抗精神病药物引起的体重增加。

IF 3.9 3区医学 Q1 PSYCHIATRY

BJPsych Open Pub Date : 2025-04-10 DOI:10.1192/bjo.2025.34

Steve Kisely, Dan Siskind, Helene Speyer

引用次数: 0

摘要

肥胖是严重精神疾病患者的一个主要健康问题，与慢性病风险增加和预期寿命缩短有关。这可归因于多种因素，包括生活方式、社会环境、药物副作用和疾病本身。第二代抗精神病药物尤其与体重增加有关，影响治疗依从性、症状和生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain.

Obesity is a major health problem among people with severe mental illness, linked to increased risk of chronic diseases and reduced life expectancy. This is attributable to a combination of factors, including lifestyle, social circumstances, medication side-effects and the illness itself. Second-generation antipsychotics are particularly associated with weight gain, affecting treatment adherence, symptoms and quality of life.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

BJPsych Open Medicine-Psychiatry and Mental Health

CiteScore

6.30

自引率

3.70%

发文量

610

审稿时长

16 weeks

期刊介绍： Announcing the launch of BJPsych Open, an exciting new open access online journal for the publication of all methodologically sound research in all fields of psychiatry and disciplines related to mental health. BJPsych Open will maintain the highest scientific, peer review, and ethical standards of the BJPsych, ensure rapid publication for authors whilst sharing research with no cost to the reader in the spirit of maximising dissemination and public engagement. Cascade submission from BJPsych to BJPsych Open is a new option for authors whose first priority is rapid online publication with the prestigious BJPsych brand. Authors will also retain copyright to their works under a creative commons license.